vs
ESSENTIAL PROPERTIES REALTY TRUST, INC.（EPRT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是ESSENTIAL PROPERTIES REALTY TRUST, INC.的1.4倍（$219.9M vs $158.8M），ESSENTIAL PROPERTIES REALTY TRUST, INC.净利率更高（37.8% vs -1.0%，领先38.8%），ESSENTIAL PROPERTIES REALTY TRUST, INC.同比增速更快（22.8% vs 2.0%），过去两年ESSENTIAL PROPERTIES REALTY TRUST, INC.的营收复合增速更高（20.6% vs 8.0%）
Essential Properties Realty Trust是一家上市房地产投资信托企业，收购、持有并管理美国全境的单租户净租赁商业地产组合，资产主要覆盖休闲餐饮、汽车服务、医疗诊所、幼儿教育中心、轻型工业等刚需服务类业态，租户普遍拥有稳健的长期经营记录。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EPRT vs OFIX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $158.8M | $219.9M |
| 净利润 | $60.0M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 56.5% | 0.2% |
| 净利率 | 37.8% | -1.0% |
| 营收同比 | 22.8% | 2.0% |
| 净利润同比 | 6.5% | 92.4% |
| 每股收益（稀释后） | $0.28 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $158.8M | — | ||
| Q4 25 | $149.9M | $219.9M | ||
| Q3 25 | $144.9M | $205.6M | ||
| Q2 25 | $137.1M | $203.1M | ||
| Q1 25 | $129.4M | $193.6M | ||
| Q4 24 | $119.7M | $215.7M | ||
| Q3 24 | $117.1M | $196.6M | ||
| Q2 24 | $109.3M | $198.6M |
| Q1 26 | $60.0M | — | ||
| Q4 25 | $68.1M | $-2.2M | ||
| Q3 25 | $65.6M | $-22.8M | ||
| Q2 25 | $63.2M | $-14.1M | ||
| Q1 25 | $56.1M | $-53.1M | ||
| Q4 24 | $55.4M | $-29.1M | ||
| Q3 24 | $49.1M | $-27.4M | ||
| Q2 24 | $51.5M | $-33.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
| Q1 26 | 56.5% | — | ||
| Q4 25 | 65.9% | 0.2% | ||
| Q3 25 | 64.7% | -8.3% | ||
| Q2 25 | 64.1% | -7.9% | ||
| Q1 25 | 61.6% | -25.2% | ||
| Q4 24 | 66.1% | -5.3% | ||
| Q3 24 | 59.7% | -9.6% | ||
| Q2 24 | 61.1% | -12.5% |
| Q1 26 | 37.8% | — | ||
| Q4 25 | 45.4% | -1.0% | ||
| Q3 25 | 45.3% | -11.1% | ||
| Q2 25 | 46.1% | -6.9% | ||
| Q1 25 | 43.4% | -27.4% | ||
| Q4 24 | 46.3% | -13.5% | ||
| Q3 24 | 42.0% | -13.9% | ||
| Q2 24 | 47.1% | -16.8% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.34 | $-0.05 | ||
| Q3 25 | $0.33 | $-0.57 | ||
| Q2 25 | $0.32 | $-0.36 | ||
| Q1 25 | $0.29 | $-1.35 | ||
| Q4 24 | $0.31 | $-0.76 | ||
| Q3 24 | $0.27 | $-0.71 | ||
| Q2 24 | $0.29 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.2M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.4B | $450.0M |
| 总资产 | $7.2B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $15.2M | — | ||
| Q4 25 | $60.2M | $82.0M | ||
| Q3 25 | $23.8M | $62.9M | ||
| Q2 25 | $20.8M | $65.6M | ||
| Q1 25 | $47.0M | $58.0M | ||
| Q4 24 | $40.7M | $83.2M | ||
| Q3 24 | $32.7M | $30.1M | ||
| Q2 24 | $23.6M | $26.4M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.6B | $157.2M | ||
| Q2 25 | $2.3B | $157.0M | ||
| Q1 25 | $2.1B | $156.9M | ||
| Q4 24 | $2.1B | $157.0M | ||
| Q3 24 | $2.2B | $118.5M | ||
| Q2 24 | $1.9B | $118.0M |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $4.2B | $450.0M | ||
| Q3 25 | $3.8B | $442.5M | ||
| Q2 25 | $3.8B | $458.3M | ||
| Q1 25 | $3.8B | $458.3M | ||
| Q4 24 | $3.6B | $503.1M | ||
| Q3 24 | $3.2B | $525.9M | ||
| Q2 24 | $3.2B | $546.0M |
| Q1 26 | $7.2B | — | ||
| Q4 25 | $6.9B | $850.6M | ||
| Q3 25 | $6.6B | $832.6M | ||
| Q2 25 | $6.3B | $837.2M | ||
| Q1 25 | $6.1B | $823.1M | ||
| Q4 24 | $5.8B | $893.3M | ||
| Q3 24 | $5.5B | $867.9M | ||
| Q2 24 | $5.3B | $882.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.69× | 0.36× | ||
| Q2 25 | 0.61× | 0.34× | ||
| Q1 25 | 0.56× | 0.34× | ||
| Q4 24 | 0.60× | 0.31× | ||
| Q3 24 | 0.69× | 0.23× | ||
| Q2 24 | 0.59× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $381.1M | $27.7M | ||
| Q3 25 | $99.0M | $12.4M | ||
| Q2 25 | $99.8M | $11.6M | ||
| Q1 25 | $77.2M | $-18.4M | ||
| Q4 24 | $308.5M | $23.7M | ||
| Q3 24 | $73.5M | $11.7M | ||
| Q2 24 | $81.1M | $9.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% |
| Q1 26 | — | — | ||
| Q4 25 | 5.60× | — | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 1.38× | — | ||
| Q4 24 | 5.57× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
